Postpartum etonogestrel-releasing implants and depression
June 24th 2020Rates of depression at 6 weeks postpartum among adolescents and young adults (AYA) were significantly lower in those initiating immediate postpartum etonogestrel (ENG) implants compared to other birth control methods, according to new research.
Juneteenth: Celebrating Black women in obstetrics and gynecology
June 19th 2020June 19, 1865, also known as Juneteenth, celebrates the end of slavery in the United States. On this day nearly 160 years ago, Union troops arrived in Galveston, TX to announce the end of the Civil War and the emancipation of slavery in the United States.
Adjunct surgical techniques safe for complex ovarian cancer cytoreduction
June 18th 2020Adjunct surgical techniques such as ultrasonic aspiration and argon-enhanced electrocautery may be safely incorporated during primary debulking surgery for patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer with miliary disease, according to a retrospective study in the International Journal of Gynecologic Cancer.
Port-site local anesthetic injection for laparoendoscopic surgery
June 18th 2020A South Korean prospective study has concluded that an injection of port-site bupivacaine hydrochloride following gynecologic laparoendoscopic single-site surgery (LSSS) does not provide any additive effect in alleviating postoperative umbilical pain.
Impact of endometrial thickness and abnormal uterine bleeding on endometrial cancer
June 17th 2020A prospective observational study has assessed the clinical relevance of endometrial thickness and abnormal uterine bleeding to endometrial cancer risk in a cohort of postmenopausal patients undergoing diagnostic hysteroscopy and endometrial biopsy.
Sex education to improve sexual health outcomes for Latinx teens
June 17th 2020The type and depth of sex education can vary, depending on the form (e.g., comprehensive vs. abstinence only), and other societal and cultural influences. For many teenagers, including Latinx, this could lead to negative sexual health outcomes.
Survival benefit in advanced or metastatic breast cancer with visceral metastases
June 12th 2020Findings from a new study show significant overall survival benefit of Novartis’ ribociclib in hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer with visceral metastases.
The Society for Maternal-Fetal Medicine consult series #49 on cesarean scar pregnancy
Cesarean scar pregnancy (CSP) is a complication in which an early pregnancy implants in the scar from a prior cesarean delivery. Incidence and recognition of this condition appear to have increased over the past two decades, perhaps due to high worldwide cesarean delivery rates. The clinical presentation is variable, and many women are asymptomatic at presentation. CSP can be difficult to diagnose in a timely fashion. Ultrasound is the primary imaging modality for CSP diagnosis. Expectantly managed CSP is associated with high rates of severe maternal morbidity such as hemorrhage, placenta accreta spectrum (PAS), and uterine rupture. Given these substantial risks, pregnancy termination is recommended after CSP diagnosis. Several surgical and medical treatments have been described for this disorder, but at this time, optimal management remains uncertain.
Legally Speaking: Did contraindicated hysterectomy lead to HIT and limb loss?
June 11th 2020The patient had a history of fibroid uterus and dilated pelvic vessels in the left adnexal region, obscuring the left ovary. On April 2, 2014, the patient was seen as a gyn outpatient at the clinic by Defendant OB. The patient complained it caused her urinary tract irritative symptoms and back pain. An MRI was ordered for evaluation. A 9.9cm exophytic fibroid arising from the posterior uterine body with focal cystic degeneration was seen.
Prepregnancy hemoglobin A1c and risk of maternal complications
June 10th 2020Canadian researchers say that prepregnancy elevated levels of hemoglobin A1C—even below thresholds for diabetes mellitus (DM)—may increase risk of severe maternal morbidity. The findings are from a population-based cohort study published in PLoS Medicine.